Day OneTuesday, 10 December 2024 - CST/CDT (Central Daylight, GMT-5)

Kick off the conference with a comprehensive discussion on PBM landscape over the past year by delving into the evolving trends and emerging challenges shaping the current industry today.

• Gain insights into the latest legislative updates and proposed federal bills impacting PBM operations.
• Explore congressional decisions on spread pricing, rebate transparency, Group Purchasing Organizations (GPOs), and other critical aspects driving PBM reform efforts.

• Explore the concept of alternative PBMs as value-added players withing pharmacy network pricing frameworks.
• Delve into the intricacies of rebate eligibility.
• Discuss the market impacts of innovative models Mark Cubans Cost Plus Drugs and Amazon’s pharmacy model.

Join us for an in depth exploration of the J&J lawsuit as we discuss:

• The expansion of data access and how that has reshaped the PBM landscape

• The importance of employers’ fiduciary duties

Conclude our in-depth exploration on the J&J lawsuit, what this entails for PBMs moving forward. And the potential opportunities this might create for middle market PBMs.

• Understand the distinctions between vertically integrated and alternative dispensing models
• Discuss impacts to PBM contract terms if alternative dispensing models are leveraged

Delve into the intricacies of contract language as we explore how various PBMs manage their contracting processes with plan sponsors to create successful contracts.

Explore the intricacies of spread pricing and its impact on drug cost management and reimbursements, highlighting the financial interplay between pharmacies, PBMs and plan sponsors.

• Dissect the multifaceted relationship between the 340B Drug Pricing Program and PBM contracting.
• Explore both the opportunities and challenges presented by 340B.